Canada· CA-DIN-02257270
ZYMAR
A gatifloxacin product containing gatifloxacin, registered in Canada by ABBVIE CORPORATION.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- GATIFLOXACIN
- Manufacturer
- ABBVIE CORPORATION
- Country
- Canada (CA)
- ATC code
- S01AE06
- ATC class
- Gatifloxacin
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gatifloxacin in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b436cc0d-7bf6-4f4b-9b10-1beacd570073 GET /v1/drugs/b436cc0d-7bf6-4f4b-9b10-1beacd570073?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02257270",
"form": "SOLUTION",
"class": "Human",
"routes": [
"OPHTHALMIC"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "S01AE06",
"schedule": [
"Prescription"
],
"drug_code": "74247",
"strengths": [
"0.3 %"
],
"ahfs_class": null,
"substances": [
"GATIFLOXACIN"
],
"product_categorization": null
}See everything about gatifloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.